Budget Express 2026

co-presented by

ASSOCIATE SPONSORS

HomeNewsJashvik capital

Jashvik Capital

Jump to

Jashvik Capital and Futura Surgicare to jointly build products for medical industry

The Indian medical devices opportunity is large and growing – roughly $11.25 billion of domestic demand and $3 billion of global demand that can be serviced from India
PE firm Jashvik Capital raises $350 million in the first close of its maiden fund

The firm invests in profitable growth businesses in the healthcare, pharma and consumer sectors in India
Corporate Crossings | Anil Matai, Vijender Singh join Jashvik Capital as operating partners

Anil Matai most recently served as CEO of Novartis Pharma India whereas Vijender Singh last served as COO of Dr. Lal's Pathlabs, India's top healthcare diagnostics company.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347